Your Source for Venture Capital and Private Equity Financings

Select An Article

Validity Secures $20M in Series E
2012-10-18
SAN JOSE, CA, Leader in Natural ID authentication, today announced that it has secured approval for $20 million in Series E financing.
Read More
Neurovance Closes $7M Series A1 Round
2012-10-18
CAMBRIDGE, MA, Neurovance, Inc. today announced that it has closed a $7 million series A1 round led by existing investor Novartis Venture Fund.
Read More
Intacct Secures $13.5M
2012-10-18
ORLANDO, FL, Leader in cloud financial management and accounting software, today announced it has secured an additional $13.5 million of financing. The majority of the new financing was secured through a $7.5 million venture funding round led by Split Rock Partners. $6M was obtained in a line of credit.
Read More
Roboinvest Raises $125K Angel Funding
2012-10-18
NEW YORK, NY, Web and mobile service for following the trades of leading traders & investors in real time, today announces the raising of $125,000 in angel round funding.
Read More
Parchment Raises $23.5M Series D
2012-10-18
SCOTTSDALE, AZ, Education credentials data pioneer Parchment Inc. has raised $23.5 million in its Series D round of funding led by The Raine Group.
Read More
Prism Skylabs Raises $7.5M Series A
2012-10-18
SAN FRANCISCO, CA, Company helping retail organizations extract invaluable intelligence about activity within their physical stores, today announced that it has closed a $7.5 million Series A funding.
Read More
Zagster Raises $1M
2012-10-18
CAMBRIDGE, MA, Company that provides bikes-as-a-service, today announced it has raised $1,000,000 in funding, led by LaunchCapital and including Fontinalis Partners.
Read More
BloomReach Raises $25M Series C
2012-10-18
MOUNTAIN VIEW, CA, Creators of big data marketing applications, today announced $25 million in Series C funding, led by New Enterprise Associates.
Read More
APIM Therapeutics Closes Financing Round
2012-10-18
TRONDHEIM, NORWAY, Financing will be used to further develop APIM Therapeutics lead anti-cancer compound towards late preclinical development.
Read More